Medics have issued an urgent warning around an experimental weight loss medication which is currently undergoing clinical ...

Compounding of this drug is currently illegal under federal law in the U.S. However, buzz around the drug’s effectiveness has led many people to seek it out online from companies or platforms that ...

If you’re confused about the growing landscape of weight loss drugs, here is a concise breakdown of their mechanisms, ...

Retatrutide weight loss drug trials recorded 28.3% average body weight loss, outpacing surgery and all existing GLP-1 ...

Retatrutide isn't supposed to be everywhere. Touted as the next generation in the GLP-1 craze, it's an experimental weight-loss drug that is not authorized outside of clinical trials. The Food and ...

There might soon be a new weight loss treatment king on top. This week, Eli Lilly posted the first large-scale trial results of its experimental combination drug retatrutide—and it’s a whopper of a ...

Retatrutide, a powerful experimental weight-loss drug that mimics three different hormones the body produces after eating, helped people lose 70 pounds on average, or 28% of their body weight, ...

Retatrutide is a triple agonist, meaning it targets three hormone receptor agonists: GLP-1, GIP and glucagon (GCG). It’s ...

It isn't approved by the FDA, but we found an experimental weight-loss drug called retatrutide for sale at a local convenience store.